We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
-15.41%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$254M
AUM Growth
-$62.7M
Cap. Flow
-$23.6M
Cap. Flow %
-9.27%
Top 10 Hldgs %
42.61%
Holding
95
New
26
Increased
21
Reduced
16
Closed
24

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$7.51M
2
BHC icon
Bausch Health
BHC
+$7M
3
MCK icon
McKesson
MCK
+$6.36M
4
AET
Aetna Inc
AET
+$5.78M
5
BIIB icon
Biogen
BIIB
+$4.95M

Top Sells

Rank Stock Value
1
RARE icon
Ultragenyx Pharmaceutical
RARE
+$10.3M
2
CELG
Celgene Corp
CELG
+$7.45M
3
STJ
St Jude Medical
STJ
+$7.31M
4
ESPR
Esperion Therapeutics
ESPR
+$6.28M
5
IPCM
IPC HEALTHCARE INC COM DTD
IPCM
+$4.15M

Sector Composition

Rank Sector Weight
1 Healthcare 74.13%
2 Financials 2.15%
3 Consumer Staples 1.24%
4 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDRX
26
DELISTED
Veradigm Inc. Common Stock
MDRX
$3.22M 1.27%
260,000
+10,000
+4% +$138K
WOOF
27
DELISTED
VCA Inc.
WOOF
$3.16M 1.24%
+60,000
New +$3.36M
TRNX
28
DELISTED
TORNIER N V SHARES (NLD)
TRNX
$3.06M 1.2%
150,000
– –
MDVN
29
DELISTED
MEDIVATION, INC.
MDVN
$2.98M 1.17%
+70,000
New +$3.47M
GBT
30
DELISTED
Global Blood Therapeutics, Inc.
GBT
$2.74M 1.08%
+65,000
New +$3.07M
XLRN
31
DELISTED
Acceleron Pharma
XLRN
$2.74M 1.08%
110,000
-40,000
-27% -$1.2M
IPXL
32
DELISTED
Impax Laboratories, Inc.
IPXL
$2.64M 1.04%
75,000
-50,000
-40% -$2.25M
AXDX
33
DELISTED
Accelerate Diagnostics
AXDX
$2.43M 0.95%
15,000
-12,000
-44% -$2.6M
NUVA
34
DELISTED
NuVasive, Inc.
NUVA
$2.41M 0.95%
50,000
– –
WMGI
35
DELISTED
Wright Medical Group Inc
WMGI
$2.1M 0.83%
100,000
– –
ONCE
36
PUT
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$2.09M 0.82%
50,000
+35,000
+233% +$1.83M
OMED
37
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$2.07M 0.82%
125,000
+25,000
+25% +$501K
SUPN icon
38
Supernus Pharmaceuticals
SUPN
$2.73B
$1.89M 0.74%
135,000
-130,000
-49% -$2.42M
ELGX
39
DELISTED
Endologix Inc
ELGX
$1.84M 0.72%
15,000
-5,000
-25% -$679K
TVTY
40
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$1.78M 0.7%
160,000
+110,000
+220% +$1.34M
DERM
41
DELISTED
Dermira, Inc.
DERM
$1.75M 0.69%
75,000
-5,000
-6% -$121K
SAGE
42
DELISTED
Sage Therapeutics
SAGE
$1.69M 0.67%
+40,000
New +$2.47M
VNDA icon
43
Vanda Pharmaceuticals
VNDA
$298M
$1.69M 0.67%
+150,000
New +$1.83M
AGTC
44
DELISTED
Applied Genetic Technologies Corporation
AGTC
$1.64M 0.65%
125,000
-25,000
-17% -$415K
PTCT icon
45
CALL
PTC Therapeutics
PTCT
$6.15B
$1.6M 0.63%
+60,000
New +$2.57M
ARIA
46
CALL
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$1.46M 0.57%
+250,000
New +$1.93M
ASMB icon
47
Assembly Biosciences
ASMB
$540M
$1.43M 0.56%
12,500
-2,083
-14% -$366K
EPZM
48
DELISTED
Epizyme, Inc
EPZM
$1.42M 0.56%
110,000
+45,000
+69% +$908K
BKD icon
49
Brookdale Senior Living
BKD
$3B
$1.38M 0.54%
+60,000
New +$1.77M
HSTO
50
DELISTED
Histogen Inc. Common Stock
HSTO
$1.33M 0.53%
1,500
+250
+20% +$228K
1
2
3 4

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q3 2015 Portfolio in Review

As of Q3 2015, Iguana Healthcare Management held 95 positions worth $254M, down 20% from $317M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Iguana Healthcare Management withdrew a net $23.6M in Q3 2015, closing 24 positions and reducing 16 holdings. Its most notable exit was St Jude Medical, an estimated $7.31M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 74% of assets, up from 68% a quarter earlier, followed by Financials and Consumer Staples.

Against the trend, Iguana Healthcare Management opened a new position in McKesson worth $5.55M.

  • Iguana Healthcare Management's largest Q3 2015 buy was McKesson: 30,000 shares worth $5.55M.
  • Iguana Healthcare Management added most to Elevance Health in Q3 2015, an estimated $7.51M increase.
  • Iguana Healthcare Management's biggest Q3 2015 reduction was Ultragenyx Pharmaceutical, cutting an estimated $10.3M.
  • Iguana Healthcare Management fully exited St Jude Medical in Q3 2015, selling an estimated $7.31M.
  • Iguana Healthcare Management's ten largest holdings make up 43% of its $254M portfolio in Q3 2015.
  • Iguana Healthcare Management opened 26 new positions and closed 24 in Q3 2015.
  • Iguana Healthcare Management's portfolio value fell 20% quarter-over-quarter to $254M.

Based on Iguana Healthcare Management's 13F filing for Q3 2015, filed 16 Nov 2015.